Literature DB >> 20075717

Validation of the Microlife WatchBP O3 device for clinic, home, and ambulatory blood pressure measurement, according to the International Protocol.

Fabio Ragazzo1, Francesca Saladini, Paolo Palatini.   

Abstract

To determine the accuracy of the Microlife WatchBP O3 blood pressure measuring device tested according to the requirements of the International Protocol of the European Society of Hypertension. The WatchBP O3 is designed to provide clinic, ambulatory, and self blood pressure (BP) measurements. Device evaluation was performed in 33 participants with a mean +/- standard deviation age of 56.1+/-20.7 years (range 30-95 years). Their systolic BP (SBP) was 144.7+/-24.1 mmHg (range 90-180 mmHg), diastolic BP (DBP) was 86.8+/-18.3 mmHg (range 50-120 mmHg), and arm circumference was 28.1+/-2.9 cm (range 22.0-34.0 cm). Blood pressure measurements were performed in the sitting position. The WatchBP O3 passed all three phases of the European Society of Hypertension protocol for SBP and DBP. Mean blood pressure differences for the WatchBP O3 (device observer) were -1.7+/-6.9 mmHg for SBP and -1.1+/-4.3 mmHg for DBP. In conclusion, these results indicate that the Microlife WatchBP O3 monitor can be recommended for clinical use in the adult population.

Entities:  

Mesh:

Year:  2010        PMID: 20075717     DOI: 10.1097/MBP.0b013e32833531ca

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  13 in total

1.  Short-term variability and nocturnal decline in ambulatory blood pressure in normotension, white-coat hypertension, masked hypertension and sustained hypertension: a population-based study of older individuals in Spain.

Authors:  Teresa Gijón-Conde; Auxiliadora Graciani; Esther López-García; Pilar Guallar-Castillón; Esther García-Esquinas; Fernando Rodríguez-Artalejo; José R Banegas
Journal:  Hypertens Res       Date:  2017-02-09       Impact factor: 3.872

2.  Patients' preference for ambulatory versus home blood pressure monitoring.

Authors:  E G Nasothimiou; N Karpettas; M G Dafni; G S Stergiou
Journal:  J Hum Hypertens       Date:  2013-10-24       Impact factor: 3.012

Review 3.  Ambulatory monitoring of central arterial pressure, wave reflections, and arterial stiffness in patients at cardiovascular risk.

Authors:  Stefano Omboni; Ayana Arystan; Bela Benczur
Journal:  J Hum Hypertens       Date:  2021-09-13       Impact factor: 3.012

4.  The AMBITIOUS Study Design and Rationale: Ambulatory Blood Pressure in Taiwanese Occupational Healthcare Staff.

Authors:  Li-Tan Yang; Po-Wei Chen; Tsung-Hsien Lin; Kuang-Hsing Chiang; Chun-Ming Shih; Ming-Chia Hsieh; Wei-Kung Tseng; Hung-I Yeh; Ping-Yen Liu
Journal:  Acta Cardiol Sin       Date:  2014-11       Impact factor: 2.672

5.  Seasonal variation in meteorological parameters and office, ambulatory and home blood pressure: predicting factors and clinical implications.

Authors:  George S Stergiou; Aikaterini Myrsilidi; Anastasios Kollias; Antonios Destounis; Leonidas Roussias; Petros Kalogeropoulos
Journal:  Hypertens Res       Date:  2015-09-03       Impact factor: 3.872

6.  Blood pressure related to age: The India ABPM study.

Authors:  Upendra Kaul; Stefano Omboni; Priyadarshini Arambam; Srinivas Rao; Sunil Kapoor; Jitendra P S Swahney; Kamal Sharma; Tiny Nair; Manoj Chopda; Jagdish Hiremath; Chandrashekhar K Ponde; Abraham Oomman; Budanur C Srinivas; Viraj Suvarna; Sanjiv Jasuja; Eric Borges; Willem J Verberk
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-11-25       Impact factor: 3.738

7.  Impact of Ambulatory Blood Pressure Monitoring on Reclassification of Hypertension Prevalence and Control in Older People in Spain.

Authors:  José R Banegas; Juan J de la Cruz; Auxiliadora Graciani; Esther López-García; Teresa Gijón-Conde; Luis M Ruilope; Fernando Rodriguez-Artalejo
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-03-16       Impact factor: 3.738

8.  Blood pressure and heart rate related to sex in untreated subjects: the India ABPM study.

Authors:  Upendra Kaul; Ajit Bhagwat; Stefano Omboni; Arvind K Pancholia; Suhas Hardas; Neil Bardoloi; Deepak Davidson; Peruvamba R Sivakadaksham; Jagdish C Mohan; Peruvamba R Vaidyanathan; Subramaniam Natarajan; Lakshnmi N P Kapardhi; Karumuri S Reddy; Dharmesh Solanki; Jitendra S Makkar; M Viswanathan; Priyadarshini Arambam; Viraj Suvarna; Willem J Verberk
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-06-17       Impact factor: 3.738

9.  Validation of the custo screen 400 ambulatory blood pressure-monitoring device according to the European Society of Hypertension International Protocol revision 2010.

Authors:  Peter Bramlage; Cornelia Deutsch; Ralf Krüger; Andreas Wolf; Peter Müller; Thomas Zwingers; Beate Beime; Thomas Mengden
Journal:  Vasc Health Risk Manag       Date:  2014-05-13

10.  Evaluation of the relationship between effervescent paracetamol and blood pressure: clinical trial.

Authors:  Mencia Benitez-Camps; Ernest Vinyoles-Bargalló; Oriol Rebagliato-Nadal; Rosa Morros-Pedrós; Helena Pera-Pujadas; Antoni Dalfó-Baqué; Ignacio López-Pavón; Carlos Roca-Sánchez; Rosa Maria Coma-Carbó; Mariano De La Figuera Von Wichmann; Lucas Mengual-Martínez; Carmen Yuste-Marco; Montserrat Teixidó-Colet; Josep M Pepió i Vilaubí; Riera Ciurana-Tost; Rosa Pou-Vila; Ma Antònia Vila-Coll; Josep Maria Bordas-Julve; Rosa Aragonès-Forès; Francisco Javier Pelegrina-Rodríguez; Josep Agudo-Ugena; Carlos Blanco-Mata; Jon de la Iglesia Berrojalbiz; Natalia Burgos-Alonso; Maria Cruz Gómez-Fernández
Journal:  BMC Cardiovasc Disord       Date:  2015-12-10       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.